Revenio Group

REG1V.HE Small Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

€19.04

-0.1% today

52W: €17.36 – €29.80

52W Low: €17.36 Position: 13.5% 52W High: €29.80

🔗 Compare Brokers

Key Metrics

P/E Ratio

29.29x

Price-to-Earnings

Forward P/E

18.74x

Forward Price/Earnings

P/S Ratio

4.61x

Price-to-Sales

EV/EBITDA

17.36x

Enterprise Value/EBITDA

Div. Yield

210%

Annual dividend yield

Market Cap

$506.6M

Market Capitalization

Revenue Growth

1.7%

YoY Revenue Growth

Profit Margin

15.85%

Net profit margin

ROE

15.66%

Return on Equity

Beta

1.05

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

48,390

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Strong Buy

5 analysts

Avg. Price Target

€23.06

+21.11% upside

Target Range

€20.80 – €25.00

About the Company

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for measuring IOP on animal patients by general veterinary practitioners, veterinary ophthalmologists and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a d

Sector: Healthcare Industry: Medical Devices Country: Finland Employees: 243 Exchange: HEL